E-selectin as a target for drug delivery and molecular imaging
- 作者：Emile Jubeli ; Laurence Moine ; Juliette Vergnaud-Gauduchon ; Gillian Barratt ; Gillian.barratt@u-psud.fr
- 关键词：E-selectin ; Endothelial cells ; Molecular targeting ; Drug delivery ; Molecular imaging ; Nanoparticles
- 刊名：Journal of Controlled Release
- 出版年：2012
- 期刊代码：25_01683659
- 类别：pha
- 出版时间：10 March, 2012
- 卷：158
- 期：2
- 页码：194-206
- 文件大小：478 K
摘要
E-selectin, also known as CD62E, is a cell adhesion molecule expressed on endothelial cells activated by cytokines. Like other selectins, it plays an important part in inflammation and in the adhesion of metastatic cancer cells to the endothelium. E-selectin recognizes and binds to sialylated carbohydrates present on the surface proteins of certain leukocytes.
E-selectin has been chosen as a target for several therapeutic and medical imaging applications, based on its expression in the vicinity of inflammation, infection or cancer. These systems for drug delivery and molecular imaging include immunoconjugates, liposomes, nanoparticles, and microparticles prepared from a wide range of starting materials including lipids, synthetic polymers, polypeptides and organo-metallic structures.
After a brief introduction presenting the selectin family and their implication in physiology and pathology, this review focuses on the formulation of these new delivery systems targeting E-selectin at a molecular level.